Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

State AGs Need Power To Pursue Online Pharmacies In Federal Court - Bliley

Executive Summary

State Attorneys General would be given authority to seek injunctions against companies illegally selling prescription drugs over the Internet in federal court under legislation to be introduced by Commerce Committee Chairman Bliley (R-Va.) and Commerce/Oversight & Investigations Subcommittee Chairman Upton (R-Mich.).

You may also be interested in...



Federal Valid Rx Standard Would Help Control Internet Pharmacies, FDA Says

A federal standard defining what constitutes a "valid prescription" would aid FDA enforcement efforts against illegal drug sales through Internet pharmacies, FDA Associate Commissioner for Regulatory Affairs John Taylor told the House Government Reform Committee March 27

Federal Valid Rx Standard Would Help Control Internet Pharmacies, FDA Says

A federal standard defining what constitutes a "valid prescription" would aid FDA enforcement efforts against illegal drug sales through Internet pharmacies, FDA Associate Commissioner for Regulatory Affairs John Taylor told the House Government Reform Committee March 27

Online Pharmacy Bill Introduced, Auguring Ongoing Oversight Debate In 2001

The introduction of a bipartisan Internet pharmacy bill as the 106th Congress draws to a close indicates that the debate on oversight of online drug sales will likely be revived in 2001.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036115

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel